In fact, this study has certain limitations and more in vivo and in vitro experiments are necessary for revealing the carcinogenic mechanism of TBC1D22A in ovarian cancer, which we are planning to do in the future. This evidence concerns the gene TBC1D22A and ovarian carcinoma.